A strong gain in exports lifted the markets to a higher open with the Dow climbing 95 points to 10,843. Nasdaq soared 31 points to 2406.
On the upside
The Food and Drug Administration approved Aeterna Zentaris' (Nasdaq: AEZS) Investigational New Drug application for its bladder cancer treatment doxorubicin targeted conjugate compound AEZS-108.
First quarter earnings for Ctrip.com (Nasdaq: CTRP) beat analyst estimates.
Delta Air Lines (NYSE: DAL) will add more flights from New York to nearly thirty cities around the world.
On the downside
Electronic Arts (Nasdaq: ERTS) forecast a greater than expected loss for the current quarter.
SunPower (Nasdaq: SPWRA) swung to a profit for the first quarter but results fell short of expectations.
The Wall Street Journal reported that Morgan Stanley (NYSE: MS) was being investigated for misleading investors.
In the broad market, advancing issues outpaced decliners by a margin of more than 4 to 1 on the NYSE and by 5 to 2 on Nasdaq. The Russell 2000 which tracks small cap stocks climbed 10 points to 705.
